Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
46
RVMD Quote, Financials, Valuation and Earnings
Last price:
$39.02
Seasonality move
:
4.95%
Day range:
$38.11 - $39.06
52-week range:
$29.17 - $62.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.44x
Volume:
1.2M
Avg. volume:
2.6M
1-year change:
-17.9%
Market cap:
$7.2B
Revenue:
$11.6M
EPS (TTM):
-$4.00
Earnings Data
Next earnings date for RVMD
Aug 07
2025
Most recent earnings per share
-$1.13
Missed by $0.07
(May 7/2025)
Consensus Estimate
-$1.06
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RVMD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $27.5M | -- | -- | -$1.18 | -- |
| 08/07/2025 | Q2 | $27.5M | -- | -- | -$1.12 | -- |
| 05/07/2025 | Q1 | -- | -- | -$1.13 | -$1.06 | -$0.07 |
| 02/26/2025 | Q4 | $346.2K | -- | -$1.12 | -$0.96 | -$0.16 |
| 11/06/2024 | Q3 | $346.2K | -- | -$0.94 | -$0.88 | -$0.06 |
| 08/07/2024 | Q2 | $807.7K | -- | -$0.81 | -$0.76 | -$0.05 |
| 05/08/2024 | Q1 | $674.2K | -- | -$0.70 | -$0.72 | $0.02 |
| 02/26/2024 | Q4 | $1.2M | $742K | -$1.21 | -$0.88 | -$0.33 |
| 11/06/2023 | Q3 | -- | -- | -$0.99 | -$1.00 | $0.01 |
| 08/08/2023 | Q2 | -- | -- | -$0.92 | -$0.82 | -$0.10 |
| 05/08/2023 | Q1 | -- | -- | -$0.72 | -$0.80 | $0.08 |
| 02/27/2023 | Q4 | -- | -- | -$0.63 | -$0.81 | $0.18 |
| 11/07/2022 | Q3 | -- | -- | -$0.87 | -$0.85 | -$0.02 |
| 08/09/2022 | Q2 | -- | -- | -$0.82 | -$0.84 | $0.02 |
| 05/09/2022 | Q1 | -- | -- | -$0.78 | -$0.77 | -$0.01 |
| 02/28/2022 | Q4 | -- | -- | -$0.71 | -$0.64 | -$0.07 |
| 11/10/2021 | Q3 | -- | -- | -$0.72 | -$0.62 | -$0.10 |
| 08/11/2021 | Q2 | -- | -- | -$0.60 | -$0.56 | -$0.04 |
| 05/10/2021 | Q1 | -- | -- | -$0.53 | -$0.52 | -$0.01 |
| 03/02/2021 | Q4 | -- | -- | -$0.52 | -$0.43 | -$0.09 |
| 11/12/2020 | Q3 | -- | -- | -$0.42 | -$0.40 | -$0.02 |
| 08/10/2020 | Q2 | -- | -- | -$0.46 | -$0.37 | -$0.09 |
| 05/14/2020 | Q1 | -- | -- | -$0.74 | -$0.36 | -$0.38 |
| 12/31/2019 | Q4 | -- | -- | -$0.36 | -$0.62 | $0.26 |
| 09/30/2019 | Q3 | -- | -- | -$0.47 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.36 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.35 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.38 | -- | -- |
Revolution Medicines Earnings Questions
-
How Much did Revolution Medicines Generate in Revenue Last Quarter?
Revolution Medicines reported -- worth of top line sales in its most recent quarter.
-
Did Revolution Medicines Beat Earnings Last Quarter?
Revolution Medicines announced earnings per share of -$1.13 which represents a miss of analyst forecast a -$1.06 per share.
-
Is Revolution Medicines Profitable?
Revolution Medicines reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Revolution Medicines EPS Next Year?
Revolution Medicines's earnings are forecast to decrease from -$3.58 per share to -$3.43 per share next year representing a decrease of -29.95%.
-
When is Revolution Medicines's Earnings Date?
Revolution Medicines's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
